Visualizing and manipulating growth hormone (GH) responses in muscle and other GH target tissues

Hormone Research

Volumn 66, Issue SUPPL. 1, 2007, Pages 35-41

  Robinson, Iain C A F ^a   Gevers, Evelien F ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

Growth hormone; Growth hormone receptor; JAK2; Muscle; Stat phosphorylation; Stat5b; Visualization

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RECEPTOR; GROWTH HORMONE RELEASING FACTOR; JANUS KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN SH2; SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 5B; STAT5 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 2; UNCLASSIFIED DRUG;

CELL FUNCTION; CONFERENCE PAPER; HEART MUSCLE; HORMONAL REGULATION; HORMONE RESPONSE; HUMAN; IMMUNOCYTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

EID: 33846492998     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000096621     Document Type: Conference Paper

References (45)

1. Woodhouse LJ, Mukherjee A, Shalet SM, Ezzat S: The influence of growth hormone status on physical impairments, functional limitations, and health-related quality of life in adults. Endocr Rev 2006;27:287-317.
2. Daughaday WH, Hall K, Raben MS, Salmon WD, Van den Brande JL, Van Wyk JJ: Somatomedin: proposed designation for sulphation factor. Nature 1972;235:107-108.
3. Butler AA, Le Roith D: Control of growth by the somatropic axis: growth hormone and the insulin-like growth factors have related and independent roles. Annu Rev Physiol 2001;63:141-164.
4. Isgaard J, Nilsson A, Lindahl A, Jansson JO, Isaksson OG: Effects of local administration of GH and IGF-1 on longitudinal bone growth in rats. Am J Physiol 1986;250:E367-E372.
5. Sjogren K, Liu JL, Blad K, Skrtic S, Vidal O, Wallenius V, LeRoith D, Tornell J, Isaksson OG, Jansson JO, Ohlsson C: Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc Natl Acad Sci USA 1999;96:7088-7092.
6. Kim J, Heshka S, Gallagher D, Kotler DP, Mayer L, Albu J, Shen W, Freda PU, Heymsfield SB: Intermuscular adipose tissue-free skeletal muscle mass: estimation by dual-energy X-ray absorptiometry in adults. J Appl Physiol 2004;97:655-660.
7. Iida K, Itoh E, Kim DS, del Rincon JP, Coschigano KT, Kopchick JJ, Thorner MO: Muscle mechano growth factor is preferentially induced by growth hormone in growth hormone-deficient lit/lit mice. J Physiol 2004;560:341-349.
8. Fryburg DA, Gelfand RA, Barrett EJ: Growth hormone acutely stimulates forearm muscle protein synthesis in normal humans. Am J Physiol 1991;260:E499-E504.
9. Fryburg DA: Insulin-like growth factor I exerts growth hormone- and insulin-like actions on human muscle protein metabolism. Am J Physiol 1994;267:E331-E336.
10. Isgaard J, Wahlander H, Adams MA, Friberg P: Increased expression of growth hormone receptor mRNA and insulin-like growth factor-I mRNA in volume-overloaded hearts. Hypertension 1994;23:884-888.
11. Ymer SI, Herington AC: Developmental expression of the growth hormone receptor gene in rabbit tissues. Mol Cell Endocrinol 1992;83:39-49.
12. Jayasankar V, Pirolli TJ, Bish LT, Berry MF, Burdick J, Grand T, Woo YJ: Targeted overexpression of growth hormone by adenoviral gene transfer preserves myocardial function and ventricular geometry in ischemic cardiomyopathy. J Mol Cell Cardiol 2004;36:531-538.
13. Fernandez AM, Dupont J, Farrar RP, Lee S, Stannard B, Le Roith D: Muscle-specific inactivation of the IGF-I receptor induces compensatory hyperplasia in skeletal muscle. J Clin Invest 2002;109:347-355.
14. Hong-Brown LQ, Brown CR, Cooney RN, Frost RA, Lang CH: Sepsis-induced muscle growth hormone resistance occurs independently of STAT5 phosphorylation. Am J Physiol Endocrinol Metab 2003;285:E63-E72.
15. Udy GB, Towers RP, Snell RG, Wilkins RJ, Park SH, Ram PA, Waxman DJ, Davey HW: Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc Natl Acad Sci USA 1997;94:7239-7244.
16. Kofoed EM, Hwa V, Little B, Woods KA, Buckway CK, Tsubaki J, Pratt KL, Bezrodnik L, Jasper H, Tepper A, Heinrich JJ, Rosenfeld RG: Growth hormone insensitivity associated with a STAT5b mutation. N Engl J Med 2003;349:1139-1147.
17. Gu Y, Zou Y, Aikawa R, Hayashi D, Kudoh S, Yamauchi T, Uozumi H, Zhu W, Kadowaki T, Yazaki Y, Komuro I: Growth hormone signalling and apoptosis in neonatal rat cardiomyocytes. Mol Cell Biochem 2001;223:35-46.
18. Rowland JE, Lichanska AM, Kerr LM, White M, d'Aniello EM, Maher SL, Brown R, Teasdale RD, Noakes PG, Waters MJ: In vivo analysis of growth hormone receptor signaling domains and their associated transcripts. Mol Cell Biol 2005;25:66-77.
19. Metcalf D, Greenhalgh CJ, Viney E, Willson TA, Starr R, Nicola NA, Hilton DJ, Alexander WS: Gigantism in mice lacking suppressor of cytokine signalling-2. Nature 2000;405:1069-1073.
20. Greenhalgh CJ, Rico-Bautista E, Lorentzon M, Thaus AL, Morgan PO, Willson TA, Zervoudakis P, Metcalf D, Street I, Nicola NA, Nash AD, Fabri LJ, Norstedt G, Ohlsson C, Flores-Morales A, Alexander WS, Hilton DJ: SOCS2 negatively regulates growth hormone action in vitro and in vivo. J Clin Invest 2005;115:397-406.
21. Way BA, Mooney RA: Activation of phosphatidylinositol-3-kinase by platelet-derived growth factor and insulin-like growth factor-1 is inhibited by a transmembrane phosphotyrosine phosphatase. J Biol Chem 1993;268:26409-26415.
22. Seely BL, Staubs PA, Reichart DR, Berhanu P, Milarski KL, Saltiel AR, Kusari J, Olefsky JM: Protein tyrosine phosphatase 1B interacts with the activated insulin receptor. Diabetes 1996;45:1379-1385.
23. Miquet JG, Sotelo AI, Bartke A, Turyn D: Suppression of growth hormone (GH) Janus tyrosine kinase 2/signal transducer and activator of transcription 5 signaling pathway in transgenic mice overexpressing bovine GH. Endocrinology 2004;145:2824-2832.
24. Le Tissier PR, Carmignac DF, Lilley S, Sesay AK, Phelps CJ, Houston P, Mathers K, Magoulas C, Ogden D, Robinson IC: Hypothalamic growth hormone-releasing hormone (GHRH) deficiency: targeted ablation of GHRH neurons in mice using a viral ion channel transgene. Mol Endocrinol 2005;19:1251-1262.
25. Clark RG, Jansson JO, Isaksson O, Robinson IC: Intravenous growth hormone: growth responses to patterned infusions. J Endocrinol 1985;104:53-61.
26. Smith PJ, Pringle PJ, Brook CG: Single dose and pulsatile treatment with human growth hormone in growth hormone deficiency. Arch Dis Child 1987;62:849-851.
27. Boersma B, Rikken B, Wit JM: Catch-up growth in early treated patients with growth hormone deficiency. Dutch Growth Hormone Working Group. Arch Dis Child 1995;72:427-431.
28. Mode A, Gustafsson JA: Sex and the liver - a journey through five decades. Drug Metab Rev 2006;38:197-207.
29. Robinson ICAF, Hindmarsh PC: The growth hormone secretory pattern and statural growth; in Kostyo J, Goodman H (eds): Handbook of Physiology. Section 7, The Endocrine System. Volume 5, Hormonal Control of Growth. Oxford, Oxford University Press, 1999, pp 329-397.
30. Legraverend C, Mode A, Wells T, Robinson I, Gustafsson JA: Hepatic steroid hydroxylating enzymes are controlled by the sexually dimorphic pattern of growth hormone secretion in normal and dwarf rats. FASEB J 1992;6:711-718.
31. Gevers EF, Wit JM, Robinson IC: Growth, growth hormone (GH)-binding protein, and GH receptors are differentially regulated by peak and trough components of the GH secretory pattern in the rat. Endocrinology 1996;137:1013-1018.
32. Isgaard J, Carlsson L, Isaksson OG, Jansson JO: Pulsatile intravenous growth hormone (GH) infusion to hypophysectomized rats increases insulin-like growth factor I messenger ribonucleic acid in skeletal tissues more effectively than continuous GH infusion. Endocrinology 1988;123:2605-2610.
33. Iida K, del Rincon JP, Kim DS, Itoh E, Coschigano KT, Kopchick JJ, Thorner MO: Regulation of full-length and truncated growth hormone (GH) receptor by GH in tissues of lit/lit or bovine GH transgenic mice. Am J Physiol Endocrinol Metab 2004;287:E566-E573.
34. Gevers EF, van der Eerden BC, Karperien M, Raap AK, Robinson IC, Wit JM: Localization and regulation of the growth hormone receptor and growth hormone-binding protein in the rat growth plate. J Bone Miner Res 2002;17:1408-1419.
35. Gabrielsson BG, Carmignac DF, Flavell DM, Robinson IC: Steroid regulation of growth hormone (GH) receptor and GH-binding protein messenger ribonucleic acids in the rat. Endocrinology 1995;136:209-217.
36. Ketelslegers JM, Maiter D, Maes M, Underwood LE, Thissen JP: Nutritional regulation of insulin-like growth factor-I. Metabolism 1995;44:50-57.
37. Alexander WS: Suppressors of cytokine signalling (SOCS) in the immune system. Nat Rev Immunol 2002;2:410-416.
38. Rakesh K, Agrawal DK: Controlling cytokine signaling by constitutive inhibitors. Biochem Pharmacol 2005;70:649-657.
39. Sawczenko A, Azooz O, Paraszczuk J, Idestrom M, Croft NM, Savage MO, Ballinger AB, Sanderson IR: Intestinal inflammation-induced growth retardation acts through IL-6 in rats and depends on the -174 IL-6 G/C polymorphism in children. Proc Natl Acad Sci USA 2005;102:13260-13265.
40. Ross RJ, Esposito N, Shen XY, Von Laue S, Chew SL, Dobson PR, Postel-Vinay MC, Finidori J: A short isoform of the human growth hormone receptor functions as a dominant negative inhibitor of the full-length receptor and generates large amounts of binding protein. Mol Endocrinol 1997;11:265-273.
41. Dattani MT, Hindmarsh PC, Brook CG, Robinson IC, Marshall NJ: Inhibition of growth hormone bioactivity by recombinant human growth hormone-binding protein in the eluted stain assay system. J Endocrinol 1994;140:445-453.
42. Fairhall KM, Carmignac DF, Robinson IC: Growth hormone (GH) binding protein and GH interactions in vivo in the guinea pig. Endocrinology 1992;131:1963-1969.
43. Ahmad F, Considine RV, Bauer TL, Ohannesian JP, Marco CC, Goldstein BJ: Improved sensitivity to insulin in obese subjects following weight loss is accompanied by reduced protein-tyrosine phosphatases in adipose tissue. Metabolism 1997;46:1140-1145.
44. Tappia PS, Atkinson PG, Sharma RP, Sale GJ: Regulation of an hepatic low-M(r) membrane-associated protein-tyrosine phosphatase. Biochem J 1993;292:1-5.
45. Clemmons DR: Roles of insulin-like growth factor-I and growth hormone in mediating insulin resistance in acromegaly. Pituitary 2002;5:181-183.